Jeena Sikho Lifecare quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Q1 FY26	Change
Revenue	224	174	+28.8%
EBITDA	92.1	78.8	+16.9%
EBITDA margin	41.0%	45.2%	−4.2 pts
Profit before tax	87.5	68.5	+27.8%
Net profit	65.9	51.3	+28.5%
EPS	₹5.30	₹4.13	+28.3%

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025	Q1 FY26Jun 2025

Expenses
	224	216	222	190	174
	14.3	3.4	2.6	1.4	1.1
	239	219	224	191	175
	27.0	27.7	26.0	25.6	13.6
	−1.4	−2.8	−1.8	−1.5	−2.5
	44.2	46.0	39.3	33.2	30.0
	3.5	3.7	3.1	4.3	1.7
	15.4	16.4	11.3	10.4	9.7
	62.5	66.7	57.5	40.6	54.5
	151	158	135	113	107
	92.1	77.9	101	92.0	78.8
	76.7	61.5	89.5	81.6	69.1
Profit
	87.5	61.2	88.9	78.7	68.5
	87.5	61.2	88.9	78.7	68.5
	21.4	17.9	24.0	20.5	17.8
	0.3	−1.7	−1.6	−0.5	−0.5
	21.6	16.1	22.3	20.0	17.2
	65.9	45.1	66.6	58.8	51.3
	65.9	45.1	66.6	58.8	51.3
	0.5	0.1	0.0	0.1	0.4
	66.4	45.1	66.6	58.8	51.7
	65.9	45.1	66.7	—	51.3
	−0.1	−0.1	−0.1	—	−0.0
Per share
	₹5.30	₹3.63	₹5.36	₹4.73	₹4.13
	₹5.29	₹3.62	₹5.35	₹4.72	₹4.12
Other comprehensive income — detail
	0.5	0.1	0.0	0.1	0.4
	—	0.1	0.0	—	—
	−0.5	−0.0	0.0	−0.1	−0.4
	66.4	45.2	66.7	—	51.7
	−0.1	−0.1	−0.1	—	−0.0
Per share — as-filed variants
	₹5.30	₹3.63	₹5.36	₹4.73	₹4.13
	₹5.29	₹3.62	₹5.35	₹4.72	₹4.12
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	199	191	197	166	163
	88.6%	88.4%	89.1%	87.3%	93.6%
Adjusted (ex-exceptional items) — derived
	87.5	61.2	88.9	78.7	68.5
	65.9	45.1	66.6	58.8	51.3
	₹5.30	₹3.63	₹5.36	₹4.73	₹4.13

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

JSLL₹347.75

Jeena Sikho Lifecare Ltd.

· Consumer Services

Annual Quarterly₹ CrorePeersJUSTDIAL IXIGO INOXGREEN HEMIPROP MANYAVAR MEDPLUS GPPL MSTCLTDMcap ₹4,323 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q1 FY26 30/06/2025	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	174.3	189.8	221.7	215.6	224.4
Other Income	1.1	1.4	2.6	3.4	14.3
Total Income	175.4	191.3	224.2	219.0	238.7
Expenses
+ Purchases of Stock-in-Trade	13.6	25.6	26.0	27.7	27.0
+ Changes in Inventories	-2.5	-1.5	-1.8	-2.8	-1.4
+ Employee Benefit Expense	30.0	33.2	39.3	46.0	44.2
+ Finance Costs	1.7	4.3	3.1	3.7	3.5
+ Depreciation & Amortisation	9.7	10.4	11.3	16.4	15.4
+ Other Expenses	54.5	40.6	57.5	66.7	62.5
Total Expenses	106.8	112.6	135.3	157.7	151.2
EBITDA	78.8	92.0	100.7	77.9	92.1
EBIT	69.1	81.6	89.5	61.5	76.7
Profit
PBT before Exceptional Items	68.5	78.7	88.9	61.2	87.5
Pretax Income	68.5	78.7	88.9	61.2	87.5
+ Current Tax	17.8	20.5	24.0	17.9	21.4
+ Deferred Tax	-0.5	-0.5	-1.6	-1.7	0.3
Tax Expense	17.2	20.0	22.3	16.1	21.6
Net Income	51.3	58.8	66.6	45.1	65.9
+ Net Income — Continuing Ops	51.3	58.8	66.6	45.1	65.9
+ Other Comprehensive Income	0.4	0.1	0.0	0.1	0.5
Total Comprehensive Income	51.7	58.8	66.6	45.1	66.4
Net Income to Common	51.3	—	66.7	45.1	65.9
Minority Interest	-0.0	—	-0.1	-0.1	-0.1
Per Share
Basic EPS	4.13	4.73	5.36	3.63	5.30
Diluted EPS	4.12	4.72	5.35	3.62	5.29
Other Comprehensive Income — detail
+ Other Comprehensive Income	0.4	0.1	0.0	0.1	0.5
+ Items NOT to be Reclassified to P&L	—	—	0.0	0.1	—
+ Tax on Items NOT to be Reclassified	-0.4	-0.1	0.0	-0.0	-0.5
Comprehensive Income — Owners of Parent	51.7	—	66.7	45.2	66.4
Comprehensive Income — Non-controlling Interests	-0.0	—	-0.1	-0.1	-0.1
Per Share — as-filed variants
Basic EPS — Continuing Operations	4.13	4.73	5.36	3.63	5.30
Diluted EPS — Continuing Operations	4.12	4.72	5.35	3.62	5.29
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	163.2	165.8	197.5	190.6	198.7
Gross Margin %	93.63	87.31	89.08	88.44	88.56
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	68.5	78.7	88.9	61.2	87.5
Net Income Adj (tax-effected)	51.3	58.8	66.6	45.1	65.9
EPS Adj	4.13	4.73	5.36	3.63	5.30
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	2.00	2.00	2.00	2.00	2.00
Paid Up Equity Capital	24.9	24.9	24.9	24.9	24.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Jeena Sikho Lifecare quarterly results

Jeena Sikho Lifecare (NSE: JSLL) has not yet announced the date of its Q2 FY27 results (July–September 2026); they are due by 14 November 2026 under SEBI's 45-day rule. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹65.9 crore, up 28.6% from ₹51.3 crore in Q1 FY26 and up 46.1% from ₹45.1 crore in Q4 FY26. Revenue from operations was ₹224 crore, up 28.8% year on year and up 4.1% from the previous quarter.

Q2 FY26 results (a year earlier): 6 November 2025

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results due by: 14 November 202645 days after the quarter (SEBI)
Q1 FY27 net profit: ₹65.9 Cr+28.6% vs Q1 FY26+46.1% vs Q4 FY26
Q1 FY27 revenue: ₹224 Cr+28.8% vs Q1 FY26+4.1% vs Q4 FY26
Q1 FY27 operating margin: 34.2%−5.5 pts vs Q1 FY26+5.6 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹58.8 CrRevenue ₹190 Cr
Q1 FY27 EPS (basic): ₹5.30

Questions

When will Jeena Sikho Lifecare announce its Q2 FY27 results?

The date is not announced yet. Results for July–September 2026 are due by 14 November 2026 (45 days after the quarter, SEBI Regulation 33). Last year it reported Q2 FY26 on 6 November 2025.

What will Jeena Sikho Lifecare's Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹58.8 crore and revenue from operations ₹190 crore. The latest quarter, Q1 FY27, had a net profit of ₹65.9 crore and revenue of ₹224 crore.

What were Jeena Sikho Lifecare's Q1 FY27 results?

Consolidated net profit was ₹65.9 crore, up 28.6% from ₹51.3 crore in Q1 FY26 and up 46.1% from ₹45.1 crore in Q4 FY26. Revenue from operations was ₹224 crore, up 28.8% year on year and up 4.1% from the previous quarter.

How has Jeena Sikho Lifecare's profit changed over the last four quarters?

Net profit by quarter: ₹58.8 crore in Q2 FY26, ₹66.7 crore in Q3 FY26, ₹45.1 crore in Q4 FY26 and ₹65.9 crore in Q1 FY27. That is ₹236 crore over the four quarters. Revenue from operations: ₹190 crore, ₹222 crore, ₹216 crore and ₹224 crore.

What was Jeena Sikho Lifecare's net profit in FY26?

Consolidated net profit was ₹222 crore in FY26 (April 2025–March 2026). It was ₹11.2 crore in FY22.

What was Jeena Sikho Lifecare's revenue in FY26?

Revenue from operations was ₹801 crore in FY26 (April 2025–March 2026). It was ₹147 crore in FY22.

Where do these Jeena Sikho Lifecare figures come from?

From Jeena Sikho Lifecare's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.